Navigation Links
NYU Langone experts find MRI techniques can detect early osteoarthritis
Date:8/15/2011

Researchers from NYU Langone Medical Center's Departments of Orthopaedic Surgery and Radiology found that advanced MRI techniques can be used to detect subtle changes in joint cartilage microstructure and provide physicians a diagnostic tool for finding key markers of early osteoarthritis (OA). By using these techniques during patient exams to identify OA earlier, clinicians can shift the management of the disease from eventual joint reconstruction to long-term preservation. The study was published in the July issue of the Journal of the American Academy of Orthopaedic Surgeons.

"Imaging technology is now sensitive and powerful enough to enable detection of subtle changes in the intricate balance of water, chondrocytes and the collagen fibers and protein molecules that make up our joint cartilage which we now know can point to future osteoarthritis," says Laith Jazrawi, MD, associate professor of orthopaedic surgery and lead author of the paper. "With an active and aging baby boomer population beginning to experience joint pain associated with age, we think there is great potential for bringing these imaging techniques from the lab to the benefit of patients."

The clinical practice standard is to use conventional MRI imaging to assess the quality of cartilage in patients with joint pain, or known arthritis, which focuses on the morphological integrity of the cartilage. In the lab, however, radiologists, orthopedic surgeons, and rheumatologists working as a team have used advances in MRI technology and biochemical imaging techniques to assess cartilage damaged by osteoarthritis. Damaged cartilage shows distinct changes in the concentration of water and collagen molecules, the micro- and macrostructure of collagen, and the concentrations of particular proteins, glycosoaminoglycans. The findings support the use of these MRI techniques in the evaluation of younger patients with joint pain to identify the beginnings of OA allowing for earlier treatment to halt the progression of the disease.

"The development and optimization of these innovative MR techniques has opened up a new window into the understanding and possible treatment of arthritis before irreversible structural and morphological changes has occurred," said Michael P. Recht, MD, Louise Marx professor of radiology and chairman of the Department of Radiology.


'/>"/>

Contact: Craig Andrews
craig.andrews@nyumc.org
212-404-3511
NYU Langone Medical Center / New York University School of Medicine
Source:Eurekalert

Related biology news :

1. NYU Langone researchers identify a signaling pathway as possible target for cancer treatment
2. NYU Langone Medical Centers tip sheet to the 2011 Alzheimers Association International Conference
3. NYU Langone experts present advances at American Association of Neurological Surgeons Meeting
4. NYU Langone Medical Center receives $5.4 million NYSTEM grant for stem cell research
5. NYU Langone Medical Center awarded NIH grants totaling $1,560,000
6. NYU Langone Medical Center researchers find micro RNA plays a key role in melanoma metastasis
7. Mobile Devices Pose New Security Risks for Patients; Five Experts Share Insights on mHealth
8. Mobile Devices Pose New Security Risks for Patients; Five Experts Share Insights on mHealth
9. Time to let science drive Great Lakes policy on Asian carp, experts say
10. Experts to speak about growth of NYC and implications for transportation policy and infrastructure
11. Experts create first legal roadmap to tackle local ocean acidification hotspots
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/13/2017)... 13, 2017  RSA Conference -- RSA, a Dell ... designed to enhance fraud detection and investigation across ... RSA Fraud & Risk Intelligence Suite. The new ... additional insights from internal and external sources as ... their customers from targeted cybercrime attacks. ...
(Date:2/8/2017)... Feb. 7, 2017  Aware, Inc. (NASDAQ: AWRE ... reported financial results for its quarter and year ended December ... of 2016 was $3.9 million compared to $6.9 million in ... quarter of 2016 was $0.6 million compared to $2.6 million ... fourth quarter of 2016 was $0.5 million, or $0.02 per ...
(Date:2/7/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and ... present at the LEERINK Partners 6th Annual Global Healthcare ... Wednesday, February 15, 2017 at 10 a.m. Eastern Time. ... can be accessed at http://wsw.com/webcast/leerink28/zbh .  The webcast ... Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com . ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... , Feb. 24, 2017  OncoSec Medical Incorporated ("OncoSec") ... will host a Key Opinion Leader event to highlight ... oral and poster presentation at the upcoming 2017 ASCO-SITC ... KOL event will be held in-person and via live ... / 9:00 AM PST at the Lotte New York ...
(Date:2/23/2017)... Feb. 23, 2017  MIODx announced today that ... key immunotherapy technologies from the University of California, ... method to monitor a patient for response to ... CTLA-4.  The second license extends the technology with ... likely to have an immune-related adverse event (IRAE) ...
(Date:2/23/2017)... ... February 23, 2017 , ... Baltimore ... multiple immunoassay-based threat detection technologies by researchers from the Pacific National Northwest ... detection technology was found to have the best level of detection (LOD) ...
(Date:2/23/2017)... , Feb. 23, 2017 Aviva ... tools, announced the acquisition of GenWay Biotech Incorporated, ... comprehensive service and product offering for both the ... will facilitate growth and enhance capabilities for both ... and ELISA assays will nicely complement ASB,s objective ...
Breaking Biology Technology: